ApotheCom delivers medical affairs and medical education solutions for pharmaceutical and biotech companies worldwide. With 250 scientific storytellers, including 130 PhDs and PharmDs, the agency creates strategic communications supporting therapies from pre commercial development through established lifecycles, specialising in oncology, rare diseases, vaccines, cell and gene therapies, and chronic disease management. The agency combines over 20 years of heritage with entrepreneurial agility. ApotheCom has guided 137 therapies across 58 technology platforms, supporting partners from emerging biotech to top 20 pharma. Its purpose built offerings bring specialist expertise where scientific storytelling shapes patient outcomes.
250
Team Members
1999
Founded
Consulting
Sector
Hybrid
Work Environment
A healthcare system where evidence based medical communications accelerate therapy development and improve patient outcomes across all therapeutic areas
ApotheCom challenges convention to accelerate outcomes through optimized medical communications, combining evidence driven insights with technology forward solutions for pharmaceutical and biotech partners